Stonebridge Capital Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Stonebridge Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 23, 2023	BUY	$314.42 - $351.91 $38,044 - $42,581	121 New	121 $42,000
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $285 - $321	-1 Reduced 3.03%	32 $9,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $25,740 - $28,719	-94 Reduced 74.02%	33 $10,000
Q2 2021 Aug 20, 2021	BUY	$187.49 - $221.1 $23,811 - $28,079	127 New	127 $26,000
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $1,797 - $2,230	-9 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $1,500 - $2,015	9 New	9 $2,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.